The metabolic activator FOXO1 binds hepatitis B virus DNA and activates its transcription

被引:48
作者
Shlomai, Amir [1 ,2 ]
Shaul, Yosef [1 ,2 ]
机构
[1] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Inst Gastroenterol & Liver Dis, IL-69978 Tel Aviv, Israel
[2] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel
关键词
Hepatitis B virus; Transcription; Metabolism; FOXO1; GENE-EXPRESSION; ENHANCER; PGC-1; GLUCONEOGENESIS; COACTIVATORS; REPLICATION; PROMOTER; BIOLOGY; DISEASE;
D O I
10.1016/j.bbrc.2009.02.078
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Hepatitis B virus (HBV) is a small DNA virus that targets the liver and infects humans worldwide. Recently we have shown that the metabolic regulator PGC-1 alpha coactivates HBV transcription thereby rendering the virus susceptible to fluctuations in the nutritional status of the liver. PGC-1 alpha coactivation of HBV is mediated through the liver-enriched nuclear receptor HNF4 alpha and through another yet unknown transcription factor(s), Here we show that the forkhead transcription factor FOXO1, a known target for PGC-1 alpha coactivation and a central mediator of glucose metabolism in the liver, binds HBV core promoter and activates its transcription. This activation is further enhanced in the presence of PGC-1 alpha, implying that FOXO1 is a target for PGC-1 alpha coactivation of HBV transcription. Thus, our results identify another key metabolic regulator as an activator of HBV transcription, thereby supporting the principle that HBV gene expression is regulated in a similar way to key hepatic metabolic genes. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:544 / 548
页数:5
相关论文
共 19 条
[1]
Enhancer I predominance in hepatitis B virus gene expression [J].
Doitsh, G ;
Shaul, Y .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (04) :1799-1808
[2]
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease [J].
Finck, BN ;
Kelly, DP .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (03) :615-622
[3]
THE MOLECULAR-BIOLOGY OF THE HEPATITIS-B VIRUSES [J].
GANEM, D ;
VARMUS, HE .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :651-693
[4]
Mechanisms of disease: Hepatitis B virus infection - Natural history and clinical consequences [J].
Ganem, D ;
Prince, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (11) :1118-1129
[5]
The role of FoxO in the regulation of metabolism [J].
Gross, D. N. ;
van den Heuvel, A. P. J. ;
Birnbaum, M. J. .
ONCOGENE, 2008, 27 (16) :2320-2336
[6]
Regulation of hepatitis B virus replication by the phosphatidylinositol 3-kinase-Akt signal transduction pathway [J].
Guo, Haitao ;
Zhou, Tianlun ;
Jiang, Dong ;
Cuconati, Andrea ;
Xiao, Guang-Hui ;
Block, Timothy M. ;
Guo, Ju-Tao .
JOURNAL OF VIROLOGY, 2007, 81 (18) :10072-10080
[7]
HNF3 binds and activates the second enhancer, ENII, of hepatitis B virus [J].
Li, M ;
Xie, YH ;
Wu, X ;
Kong, YY ;
Wang, Y .
VIROLOGY, 1995, 214 (02) :371-378
[8]
Metabolic control through the PGC-1 family of transcription coactivators [J].
Lin, JD ;
Handschin, C ;
Spiegelman, BM .
CELL METABOLISM, 2005, 1 (06) :361-370
[9]
Autorepression of Rfx1 gene expression: Functional conservation from yeast to humans in response to DNA replication arrest [J].
Lubelsky, Y ;
Reuven, N ;
Shaul, Y .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (23) :10665-10673
[10]
p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53 [J].
Ori, A ;
Zauberman, A ;
Doitsh, G ;
Paran, N ;
Oren, M ;
Shaul, Y .
EMBO JOURNAL, 1998, 17 (02) :544-553